Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 02-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||
| Accounts receivable | 0 | 1 | -2 |
| Accounts payable and accrued liabilities | N/A | 27 | -17 |
| Other Working Capital | 57 | 100 | -126 |
| Other Operating Activity | -93 | -604 | -54 |
| Operating Cash Flow | $-36 | $-476 | $-200 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 316 | 0 |
| Common Stock Issued | N/A | 0 | 353 |
| Financing Cash Flow | $0 | $316 | $353 |
| Exchange Rate Effect | N/A | -1 | 0 |
| Beginning Cash Position | 182 | 179 | 30 |
| End Cash Position | 146 | 19 | 184 |
| Net Cash Flow | $-36 | $-159 | $153 |
| Free Cash Flow | |||
| Operating Cash Flow | -36 | -476 | -200 |
| Free Cash Flow | -36 | -476 | -200 |